Mirzai, Saeid http://orcid.org/0000-0002-2579-4965
Laffin, Luke J. http://orcid.org/0000-0002-3262-792X
Article History
Accepted: 3 June 2023
First Online: 10 June 2023
Compliance with Ethical Standards
:
: Luke J. Laffin has been a consultant and/or served on steering committees for Medtronic, Lilly Pharmaceuticals, Mineralys Therapeutics, AstraZeneca, and Crispr Therapeutics; has received research funding from AstraZeneca; and has ownership interest in LucidAct Health and Gordy Health. Saeid Mirzai declares that he has no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.